Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 13 | 2020 | 971 | 2.820 |
Why?
|
| Alzheimer Disease | 7 | 2021 | 351 | 2.540 |
Why?
|
| Dementia | 7 | 2021 | 256 | 2.300 |
Why?
|
| Cognition | 6 | 2020 | 551 | 1.680 |
Why?
|
| Blood Pressure | 5 | 2018 | 859 | 1.020 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2021 | 1345 | 0.910 |
Why?
|
| Hydroxycholesterols | 2 | 2013 | 2 | 0.850 |
Why?
|
| Hypertension | 3 | 2021 | 972 | 0.840 |
Why?
|
| Disease Progression | 2 | 2014 | 618 | 0.820 |
Why?
|
| Insulin | 2 | 2015 | 368 | 0.810 |
Why?
|
| Autonomic Nervous System | 1 | 2020 | 43 | 0.700 |
Why?
|
| Cholesterol | 3 | 2020 | 251 | 0.660 |
Why?
|
| Heart | 1 | 2020 | 182 | 0.650 |
Why?
|
| Heart Rate | 1 | 2020 | 337 | 0.610 |
Why?
|
| Humans | 26 | 2021 | 32297 | 0.560 |
Why?
|
| Cerebrovascular Disorders | 2 | 2018 | 54 | 0.540 |
Why?
|
| Dementia, Vascular | 1 | 2015 | 13 | 0.540 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 1428 | 0.500 |
Why?
|
| Carotid Artery, Common | 1 | 2014 | 39 | 0.500 |
Why?
|
| Cohort Studies | 8 | 2020 | 1832 | 0.490 |
Why?
|
| Brain Ischemia | 1 | 2016 | 146 | 0.490 |
Why?
|
| Stroke | 2 | 2018 | 585 | 0.480 |
Why?
|
| African Americans | 2 | 2018 | 1443 | 0.470 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 114 | 0.460 |
Why?
|
| Biological Transport | 1 | 2013 | 73 | 0.460 |
Why?
|
| Male | 18 | 2020 | 19488 | 0.460 |
Why?
|
| Frontal Lobe | 1 | 2013 | 38 | 0.450 |
Why?
|
| Neuropsychological Tests | 4 | 2020 | 379 | 0.440 |
Why?
|
| Female | 17 | 2020 | 20126 | 0.440 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 4050 | 0.440 |
Why?
|
| Aged | 12 | 2020 | 10398 | 0.410 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 244 | 0.400 |
Why?
|
| Diabetes Complications | 3 | 2018 | 180 | 0.390 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 395 | 0.380 |
Why?
|
| Apolipoprotein E4 | 3 | 2018 | 62 | 0.360 |
Why?
|
| Aging | 2 | 2013 | 953 | 0.350 |
Why?
|
| Weight Loss | 1 | 2012 | 454 | 0.330 |
Why?
|
| Risk Factors | 5 | 2018 | 3876 | 0.330 |
Why?
|
| Cognition Disorders | 3 | 2018 | 383 | 0.330 |
Why?
|
| Age Factors | 3 | 2020 | 1204 | 0.320 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2020 | 12 | 0.300 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 1522 | 0.300 |
Why?
|
| Case-Control Studies | 3 | 2013 | 911 | 0.280 |
Why?
|
| Time Factors | 3 | 2020 | 2181 | 0.270 |
Why?
|
| Obesity | 2 | 2014 | 1164 | 0.270 |
Why?
|
| Positron-Emission Tomography | 4 | 2020 | 190 | 0.260 |
Why?
|
| Middle Aged | 8 | 2020 | 11949 | 0.260 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1133 | 0.260 |
Why?
|
| Ankle Brachial Index | 2 | 2014 | 39 | 0.230 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 877 | 0.220 |
Why?
|
| Double-Blind Method | 2 | 2014 | 550 | 0.210 |
Why?
|
| Organ Size | 2 | 2018 | 220 | 0.180 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 176 | 0.170 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 172 | 0.170 |
Why?
|
| Triglycerides | 1 | 2020 | 230 | 0.170 |
Why?
|
| Mental Health | 1 | 2020 | 113 | 0.170 |
Why?
|
| Hypotension, Orthostatic | 1 | 2018 | 12 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 57 | 0.160 |
Why?
|
| Vascular Diseases | 1 | 2019 | 66 | 0.160 |
Why?
|
| Memory | 1 | 2020 | 191 | 0.160 |
Why?
|
| Animals | 3 | 2015 | 7694 | 0.160 |
Why?
|
| Amyloid | 1 | 2018 | 20 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2018 | 147 | 0.150 |
Why?
|
| Health Status | 1 | 2020 | 402 | 0.150 |
Why?
|
| Risk | 1 | 2018 | 325 | 0.150 |
Why?
|
| Mitochondria | 1 | 2018 | 188 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3514 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 121 | 0.140 |
Why?
|
| Atrophy | 2 | 2013 | 50 | 0.140 |
Why?
|
| United States | 3 | 2020 | 3983 | 0.140 |
Why?
|
| Prognosis | 1 | 2020 | 1523 | 0.130 |
Why?
|
| Acute Disease | 1 | 2016 | 255 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2020 | 635 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 696 | 0.130 |
Why?
|
| Prediabetic State | 1 | 2015 | 65 | 0.130 |
Why?
|
| Ethnic Groups | 1 | 2018 | 480 | 0.130 |
Why?
|
| Glucose | 1 | 2015 | 177 | 0.120 |
Why?
|
| Prospective Studies | 1 | 2020 | 2274 | 0.120 |
Why?
|
| Inflammation | 1 | 2018 | 542 | 0.120 |
Why?
|
| Receptor, EphA1 | 1 | 2013 | 2 | 0.120 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 29 | 0.120 |
Why?
|
| Ginkgo biloba | 1 | 2013 | 19 | 0.120 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 31 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 60 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2013 | 61 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2013 | 296 | 0.110 |
Why?
|
| Homeostasis | 1 | 2013 | 133 | 0.110 |
Why?
|
| Overweight | 1 | 2014 | 270 | 0.110 |
Why?
|
| Pennsylvania | 1 | 2012 | 84 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2296 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2015 | 460 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 362 | 0.110 |
Why?
|
| Fasting | 1 | 2012 | 97 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2012 | 144 | 0.100 |
Why?
|
| Brain Infarction | 1 | 2011 | 10 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 786 | 0.100 |
Why?
|
| Adult | 3 | 2014 | 9467 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2018 | 770 | 0.100 |
Why?
|
| Linear Models | 1 | 2012 | 454 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2012 | 921 | 0.080 |
Why?
|
| Young Adult | 1 | 2012 | 2626 | 0.060 |
Why?
|
| Incidence | 2 | 2018 | 1207 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2012 | 3358 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 45 | 0.040 |
Why?
|
| Cerebral Angiography | 1 | 2020 | 60 | 0.040 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2019 | 9 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 50 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 101 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2018 | 122 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 64 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2018 | 201 | 0.040 |
Why?
|
| Age Distribution | 1 | 2018 | 210 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 103 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2018 | 190 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 238 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2018 | 355 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 759 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 926 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 470 | 0.030 |
Why?
|
| Hawaii | 1 | 2011 | 4 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 1447 | 0.030 |
Why?
|
| Neurofibrillary Tangles | 1 | 2011 | 7 | 0.030 |
Why?
|
| Autopsy | 1 | 2011 | 39 | 0.030 |
Why?
|
| Asian Americans | 1 | 2011 | 100 | 0.020 |
Why?
|